Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PCI Pharma Services (PCI) has announced the appointment of Melissa Ertl as Executive Director of Quality for its Philadelphia location.
read more
Bristol-Myers Squibb and Flatiron Health have expanded their relationship by announcing a three-year collaboration agreement.
read more
CGT Catapult’s cell and gene therapy manufacturing center has been officially opened by the Business Secretary Greg Clark and Science Minister Sam Gyimah.
read more
Bactevo has entered into a drug discovery collaboration agreement with Boehringer Ingelheim to identify novel small molecule lead compounds.
read more
Triumvira Immunologics announced a strategic relationship with the Centre for Commercialisation of Cancer Immunotherapy (C3i).
read more
Baxter and the International Society of Nephrology announced a partnership to advance CKD awareness and help improve access to therapy, particularly in LMIC where the disease prevalence is growing the fastest.
read more
Fresenius has decided today to terminate the company’s merger agreement with Akorn, due to Akorn’s failure to fulfill several closing conditions.
read more
Thermo Fisher has signed agreements with Daiichi Sankyo and Takeda designed to expand the clinical utility of Oncomine Dx Target Test in support of clinical trials and drug development programs.
read more
Aerie Pharmaceuticals announced the appointment of Concetta Perro as Commercial Counsel, reporting to John LaRocca, Aerie’s General Counsel.
read more
Charles River Laboratories announced the expansion of its service capabilities in early discovery screening.
read more
TheVax Genetics Vaccine and Biotechpharma have entered into a manufacturing agreement to produce THEVAX HBV vaccine for first-in-human clinical trials.
read more
Avella announced it has been selected by Otsuka to distribute Jynarque, the FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease.
read more
Lannett announced that effective July 1, 2018 current director, Patrick LePore, will become chairman of the board of directors, succeeding Jeffrey Farber, who will remain a member of the board.
read more
Lyophilization Services of New England has acquired PSC Biotech’s cGMP aseptic fill finish manufacturing facility located in Madison, Wisconsin
read more
ANI Pharmaceuticals has signed definitive agreements to acquire a portfolio of generic products and other assets from Amneal and Impax for undisclosed cash consideration.
read more